Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Amfetamine for Attention Deficit Hyperactivity Disorder in People With Intellectual Disabilities." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431770/all/Oral_immunoglobulin_for_the_prevention_of_rotavirus_infection_in_low_birth_weight_infants:_Cochrane_systematic_review. Accessed 25 April 2024.
Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431770/all/Oral_immunoglobulin_for_the_prevention_of_rotavirus_infection_in_low_birth_weight_infants:_Cochrane_systematic_review. Accessed April 25, 2024.
Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431770/all/Oral_immunoglobulin_for_the_prevention_of_rotavirus_infection_in_low_birth_weight_infants:_Cochrane_systematic_review
Amfetamine for Attention Deficit Hyperactivity Disorder in People With Intellectual Disabilities [Internet]. In: Cochrane Abstracts. [cited 2024 April 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431770/all/Oral_immunoglobulin_for_the_prevention_of_rotavirus_infection_in_low_birth_weight_infants:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities
ID - 431770
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431770/all/Oral_immunoglobulin_for_the_prevention_of_rotavirus_infection_in_low_birth_weight_infants:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -